Faculty

Mine Cicek, Ph.D.

Location

Rochester, Minnesota

Contact

Cicek.Mine@mayo.edu Clinical Profile

SUMMARY

Mine Cicek, Ph.D., is a molecular cancer genetic epidemiologist. For more than a decade, her research has focused on cancer susceptibility genes for prostate, colon and ovarian cancers.

Dr. Cicek is the director of the Mayo Clinic Biorepositories Program. She contributes her expertise to research studies and clinical trials overseeing biospecimen collections, processing and storage across the Mayo Clinic enterprise. She continuously brings new knowledge and technology to the program to improve best practices for biospecimen usage.

Focus areas

  • Biorepositories Program. This program supplies the Mayo research community with high-quality, clinically annotated biospecimens. Four core laboratories at Mayo Clinic's campuses in Arizona, Florida and Minnesota provide services for the collection, processing, storage, distribution and management of biospecimens. Dr. Cicek's program connects and unites operations among the core laboratories.
  • Cancer research. Dr. Cicek's program provides core services and resources to support cancer research, including access to cutting-edge technology and methodology, scientific consultation, reliability, cost-effectiveness, and quality control. It is one of the Mayo Clinic Comprehensive Cancer Center shared resources.
  • Alliance. The National Cancer Institute's National Clinical Trials Network Alliance for Clinical Trials in Oncology — often referred to simply as "Alliance" — represents cancer cooperative groups including the American College of Surgeons Oncology Group, the Cancer and Leukemia Group B, and the North Central Cancer Treatment Group. Dr. Cicek's program is a part of the Alliance Biorepositories and Biospecimen Resource and supports clinical cancer trials through biospecimen procurement, tracking, processing, quality assurance, storage and distribution.
  • ACCRU. The Academic and Community Cancer Research United (ACCRU) cancer research network brings together more than 60 academic and community-based cancer treatment clinics and hospitals in the United States and Canada. Dr. Cicek's program provides a full range of biospecimens services to help ACCRU support translational clinical trials to improve cancer care.

Significance to patient care

Dr. Cicek's biorepositories leadership helps provide essential infrastructure for Mayo Clinic researchers and accelerates discovery, translation and application of scientific breakthroughs that address patients' unmet needs.

Professional highlights

  • David F. and Margaret T. Grohne Director, Biorepositories Program, Mayo Clinic, 2022-present.

PROFESSIONAL DETAILS

Primary Appointment

  1. Consultant, Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology

Academic Rank

  1. Associate Professor of Laboratory Medicine and Pathology

EDUCATION

  1. Fellow - NIH R25T Mayo Cancer Genetic Epidemiology Training Fellowship Mentors: Stephen N. Thibodeau and Gloria M. Petersen Department of Laboratory Medicine and Pathology
  2. Postdoctoral Research Fellowship - Mentors: Graham Casey and John Witte Cleveland Clinic, Lerner Research Institute, Dept of Cancer Biology
  3. Ph.D. - Genetics Advisors: Glenn R. Buss and MA Saghai Maroof Genetic marker analysis of three major carbohydrates in soybean seeds Virginia Tech
  4. MS - Genetics Advisors: Glenn R. Buss and MA Saghai Maroof Genetic analysis of quantitative trait loci associated with seed sucrose content using molecular markers in an interspecific glycine cross Virginia Tech
  5. BS - Biology Hacettepe University, Ankara, Turkey

Related links

More about research at Mayo Clinic

.
BIO-20115089

Mayo Clinic Footer